UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

PloS one, 2014-09, Vol.9 (9), p.e104271

2014

Volltextzugriff (PDF)

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Nature medicine, 2016-04, Vol.22 (4), p.369-378

2016

Volltextzugriff (PDF)

Tertiary Gleason Pattern 5 in Gleason 7 Prostate Cancer Predicts Pathological Stage and Biochemical Recurrence

The Journal of urology, 2008-05, Vol.179 (5), p.1775-1779

2008

Volltextzugriff (PDF)

Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?

European urology, 2016-09, Vol.70 (3), p.542-543

Lange, Paul H

2016

Volltextzugriff (PDF)

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Journal of clinical oncology, 2004-02, Vol.22 (3), p.537-556

2004

Volltextzugriff (PDF)

Single cell transcriptomic analysis of prostate cancer cells

BMC molecular biology, 2013-02, Vol.14 (1), p.6-6, Article 6

2013

Volltextzugriff (PDF)

Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality

The Journal of urology, 2010-06, Vol.183 (6), p.2213-2218

2010

Volltextzugriff (PDF)

The biology and clinical implications of prostate cancer dormancy and metastasis

Journal of Molecular Medicine, 2016-03, Vol.94 (3), p.259-265

2016

Volltextzugriff (PDF)

A history of the Society of Urologic Oncology

Urologic oncology, 2021-09, Vol.39 (9), p.514-520

2021

Volltextzugriff (PDF)

Systemic therapy and the urologic oncologist: A unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient

Urologic oncology, 2012-07, Vol.30 (4), p.S2-S4

2012

Volltextzugriff (PDF)

Re: Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database

European urology, 2013-02, Vol.63 (2), p.402-403

Lange, Paul H

2013

Volltextzugriff (PDF)

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Journal of bone and mineral research, 2013-02, Vol.28 (2), p.333-340

2013

Volltextzugriff (PDF)

Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy

Urology (Ridgewood, N.J.), 2006-12, Vol.68 (6), p.1290-1294

2006

Volltextzugriff (PDF)

127 POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY PREDICT PROSTATE CANCER-SPECIFIC MORTALITY: SUPPORT FOR OPTIMIZING SURGICAL TECHNIQUE AND PATHOLOGICAL EVALUATION AT RADICAL PROSTATECTOMY

The Journal of urology, 2010-04, Vol.183 (4), p.e52-e52

2010

Volltextzugriff (PDF)

The future of urologic oncology: “Proceduralists” or continued leaders?

Urologic oncology, 2009-03, Vol.27 (2), p.118-119

Lange, Paul H., M.D., F.A.C.S

2009

Volltextzugriff (PDF)

Penile Carcinoma: Lessons Learned from Vulvar Carcinoma

The Journal of urology, 2013, Vol.189 (1), p.17-24

2013

Volltextzugriff (PDF)

Cystoprostatectomy and neobladder construction for florid cystitis glandularis

Urology (Ridgewood, N.J.), 2005, Vol.65 (1), p.174-174

2005

Volltextzugriff (PDF)

The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer

Urologic oncology, 2007-05, Vol.25 (3), p.214-220

2007

Volltextzugriff (PDF)

Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

European urology, 2010-08, Vol.58 (2), p.311-312

Lange, Paul H

2010

Volltextzugriff (PDF)

Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence

The American journal of surgical pathology, 2014-03, Vol.38 (3), p.333-338

2014

Volltextzugriff (PDF)

Genitourinary oncology and its surgeon scientists: Triumphant past, but does it have a future?

Urologic oncology, 2007, Vol.25 (1), p.2-10

Lange, Paul H., M.D., F.A.C.S

2007

Volltextzugriff (PDF)

Role of Post-Chemotherapy Surgery in Germ Cell Tumors

Urologic clinics of North America, 2007-05, Vol.34 (2), p.199-217

2007

Volltextzugriff (PDF)

Editorial Comment on: Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy

European urology, 2009-03, Vol.55 (3), p.609-609

Lange, Paul H

2009

Volltextzugriff (PDF)

Re: Adjuvant Radiotherapy for Patients with Locally Advanced Prostate Cancer—A New Standard?

European urology, 2009-02, Vol.55 (2), p.524-525

Lange, Paul H

2009

Volltextzugriff (PDF)

Maximal Testosterone Suppression in Prostate Cancer—Free vs Total Testosterone

Urology (Ridgewood, N.J.), 2014-06, Vol.83 (6), p.1217-1222

2014

Volltextzugriff (PDF)

1 – 25 von 526

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(523)
Mit Volltextzugriff
(311)

Publikationsform

Sprache

Englisch
(524)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Tertiary Gleason Pattern 5 in Gleason 7 Prostate Cancer Predicts Pathological Stage and Biochemical Recurrence

Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Single cell transcriptomic analysis of prostate cancer cells

Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality

The biology and clinical implications of prostate cancer dormancy and metastasis

A history of the Society of Urologic Oncology

Systemic therapy and the urologic oncologist: A unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient

Re: Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy

127 POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY PREDICT PROSTATE CANCER-SPECIFIC MORTALITY: SUPPORT FOR OPTIMIZING SURGICAL TECHNIQUE AND PATHOLOGICAL EVALUATION AT RADICAL PROSTATECTOMY

The future of urologic oncology: “Proceduralists” or continued leaders?

Penile Carcinoma: Lessons Learned from Vulvar Carcinoma

Cystoprostatectomy and neobladder construction for florid cystitis glandularis

The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer

Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence

Genitourinary oncology and its surgeon scientists: Triumphant past, but does it have a future?

Role of Post-Chemotherapy Surgery in Germ Cell Tumors

Editorial Comment on: Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy

Re: Adjuvant Radiotherapy for Patients with Locally Advanced Prostate Cancer—A New Standard?

Maximal Testosterone Suppression in Prostate Cancer—Free vs Total Testosterone

Aktive Filter

Suchergebnisse filtern